Open House Biologics Discount Agreement for Follitropin delta
Titre original de l'avis
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-07 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
62 / 100
Complexité
58 / 100
Facteurs de risque
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 4 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- Supplies contract
- 1 lot
- Duration until Jun 2026
- Open House discount agreements for pharmaceutical products, specifically Follitropin delta.
- Nationwide performance in Germany.
Afficher le résumé complet
Open House supply arrangement by Techniker Krankenkasse for the active substance Follitropin delta (CPV 33600000). The procedure is non-exclusive, with no individual negotiations and uniform terms. Participation is open throughout the contract period, but the notice states the procedure will end early on 30.08.2026 and a follow-on procedure will be launched. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the XML notice extract.
Risques
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 4 days
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant medicinal product.
- Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
- Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.
Acheteur
Localisation
Hamburg, DEU
Site web
Identifiant
992-80116-93
Activité
Health
Lots (1)
LOT-0001
Open House Biologics Discount Agreement for Follitropin delta
Supply lot for discount agreements under § 130a(8) SGB V concerning Follitropin delta. The lot is nationwide in Germany and follows Open House terms with no exclusivity and no individual negotiation. The XML notice indicates the procedure will end early on 30.08.2026, although the structured data also states a maximum contract term ending 31.05.2027; this inconsistency affects timing and should be clarified.
Localisation
Durée
Catégorie
Date limite
Détails des critères
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin delta zu schließen.
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Open House Biologika Rabattverträge 2025-07 - Follitropin delta
Description TED originale
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin delta zu schließen.
Détails de la procédure
- Date de publication
- 08 Jul 2026
- Langues
- German
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 474600-2026
Documents (1)
Appels d'offres similaires
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Score d'opportunité
Pourquoi ce score ?
Opportunité
62 / 100
Complexité
58 / 100
Facteurs de risque
The structured data states a maximum contract term ending 31.05.2027, while the XML notice says the procedure ends earl...
Electronic submission via the portal is not allowed; the XML notice requires email with qualified electronic signature...
Submission deadline in 4 days
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications